Jennifer Van Eyk, PhD

Director, Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences

Proteomic Analysis by Mass Spectrometry for Precision Medicine

Dr. Jennifer Van Eyk describes the importance of proteomics on precision medicine. She speaks about the impact that mass spectrometry has on clinical labs, and provides insights into how remote monitoring and molecular phenotyping can influence patient care.

LIKE 1


Jennifer Van Eyk, PhD
Mass Spectrometry Proteomics

Jennifer Van Eyk, PhD

Biography

Jennifer heads up the Van Eyk Laboratory at Cedars Sinai, which is interested in the molecular basis behind a variety of cardiovascular disorders. More

Jennifer Van Eyk, PhD

Director, Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences

The Van Eyk Laboratory is interested in the molecular basis behind a variety of cardiovascular disorders. Their projects range from basic discovery research to clinically relevant analytical studies. The common thread that runs through these projects is proteomics. They apply a considerable mass spectrometry-based expertise to deciphering the precise role that protein expression profiles and modifications play in disease progression. In brief, they are interested in how alterations to the proteome affect physiology. Their expertise is in merging interesting biological questions with leading-edge analytical techniques, including mass spectrometry, that help decipher protein identities, quantities and modifications. The Van Eyk Laboratory is affiliated with the Cedars-Sinai Smidt Heart Institute and the Advanced Clinical Biosystems Research Institute.